Breaking News
October 19, 2018 - The Current issue of “The view from here” is concerned with Nanotherapeutic strategies
October 19, 2018 - Delay in replacing the Pap smear with HPV screening is costing lives
October 19, 2018 - Physicians battle pediatric diseases of ear, nose, throat in Zimbabwe | News Center
October 19, 2018 - Researchers investigate why some cancers affect only young women
October 19, 2018 - Drugmakers funnel millions to lawmakers; a few dozen get $100,000-plus
October 19, 2018 - Unselfish people tend to have more children and receive higher salaries
October 19, 2018 - New findings reveal potential cellular players in tumor microenvironment
October 19, 2018 - Human brain cell transplant offers insights into neurological conditions
October 19, 2018 - Parental education associated with increased family health care spending
October 19, 2018 - New statistical method estimates long- and short-term risk of recurrence of breast cancer in US women
October 19, 2018 - Father’s exposure to nicotine may cause cognitive deficits in descendants
October 19, 2018 - Could we prevent Alzheimer’s disease by treating herpes?
October 19, 2018 - Nurse-led care can be more successful in managing gout
October 19, 2018 - Trump administration, pharma exchange verbal volleys on drug-price transparency
October 19, 2018 - Duke researchers find way to detect blood doping in athletes
October 19, 2018 - Many primary care doctors are still prescribing sedative drugs for older adults
October 19, 2018 - Finger length can predict sexuality in women say researchers
October 19, 2018 - Study finds differences in side-effects experienced by male and female OG cancer patients
October 19, 2018 - Few Seniors Who Self-Harm Referred for Mental Health Care
October 19, 2018 - Don’t sweat the sweet stuff
October 19, 2018 - URMC researchers discover new approach to deliver therapeutics to the brain
October 19, 2018 - Middlemen suppliers can increase drug prices and hospital bills, say Johns Hopkins researchers
October 19, 2018 - Human neurons employ highly compartmentalized signaling, study shows
October 19, 2018 - Ultromics expands multiple clinical trials for coronary heart disease to the U.S.
October 19, 2018 - $11 million NIH grant for Clemson University helps launch new center for musculoskeletal research
October 19, 2018 - A new approach identified to control Zika virus, dengue fever
October 19, 2018 - Head Blows Without Concussion May Not Damage Brain, Study Claims
October 19, 2018 - US opioid use not declined, despite focus on abuse and awareness of risk
October 19, 2018 - Next-generation RNA sequencing technology sheds new light on human mitochondrial diseases
October 19, 2018 - UT Southwestern biochemist receives 2019 Breakthrough Prize in Life Sciences for innate immunity discovery
October 19, 2018 - The immune system also plays a key role in day-to-day function of healthy organs
October 19, 2018 - New tool may reveal how the brain structure impacts brain activity, human behavior
October 19, 2018 - Trump Administration announces ‘Winning on Reducing Food Waste’ initiative
October 19, 2018 - For-profit nursing home residents more likely to experience health issues caused by substandard care
October 19, 2018 - Incidence of stroke has risen steadily among marijuana users, show studies
October 19, 2018 - Conceptual framework proposed to examine role of exercise in multiple sclerosis
October 19, 2018 - Near infrared spectroscopy technique for accurate evaluation of chondral injuries
October 19, 2018 - Scientists receive $5.1 million grant to develop stem cell-based therapy for blinding retinal conditions
October 19, 2018 - Shorter physician encounters associated with antibiotic prescribing
October 19, 2018 - In the Spotlight: Enjoying research and exploring opportunities
October 19, 2018 - Physical activity lowers cardiovascular mortality risk in frail older adults
October 19, 2018 - New imaging tool helps visualize how sound-induced vibrations travel through the ear
October 19, 2018 - Key insights into the application, production of bioactive materials
October 19, 2018 - New urea sorbent could speed up the development of wearable artificial kidney
October 19, 2018 - Intensive care patients’ muscles less able to use fats for energy
October 19, 2018 - FDA Advisory Committee Recommends Approval of Dsuvia for the Treatment of Moderate-to-Severe Acute Pain
October 19, 2018 - 48,XXXY syndrome – Genetics Home Reference
October 19, 2018 - Physical exercise improves the elimination of toxic proteins from muscles
October 19, 2018 - How a new system improved wait times for Stanford kidney transplant patients
October 19, 2018 - Nutrition has bigger positive impact on bone mass and strength than exercise
October 19, 2018 - Study finds lack of progress in media representation of nurses over last 20 years
October 19, 2018 - Many people have trouble understanding differences between OCD and OCPD
October 19, 2018 - New family planning app found to be as effective as modern methods
October 19, 2018 - Gastric Banding, Metformin Similar for Improving Glycemia
October 19, 2018 - Physiologist publishes findings on the role of the protein titin in muscle contraction
October 19, 2018 - What digital health companies need to do to succeed
October 19, 2018 - N. Carolina Sees Alarming Spike in Heart Infections Among Opioid Users
October 19, 2018 - Video monitoring of TB therapy works well in urban and rural areas
October 19, 2018 - Determining acid-neutralizing capacity for OTC antacids
October 19, 2018 - Males who spend more time taking care of kids have greater reproductive success
October 18, 2018 - Study to explore bioethics of brain organoids
October 18, 2018 - Environmental conditions may drive development of multiple sclerosis
October 18, 2018 - Genetically modifying zebrafish provides more accurate disease models
October 18, 2018 - Purdue Pharma, Eisai announce positive topline results from Phase 3 study of lemborexant
October 18, 2018 - 5 Strength-Training Mistakes to Avoid
October 18, 2018 - Immune system’s balancing act keeps bowel disease in check
October 18, 2018 - Anti-inflammatory drug effective for treating lymphedema symptoms | News Center
October 18, 2018 - Keeping Your Voice Young
October 18, 2018 - One-time universal screening recommended to tackle increase in hepatitis C
October 18, 2018 - Researchers to develop new stem cell-based strategies for treating vision disorders
October 18, 2018 - Detecting epigenetic signature may help people stay ahead of inflammatory bowel disease
October 18, 2018 - Understanding AFib: Slowing down the dancing heart
October 18, 2018 - Using NMR to Reduce Fraud
October 18, 2018 - New automated model identifies dense breast tissue in mammograms
October 18, 2018 - Mysterious polio-like illness baffles medical experts while frightening parents
October 18, 2018 - Cases of Acute Flaccid Myelitis on the rise across U.S.
October 18, 2018 - Dietary fiber reduces brain inflammation during aging
October 18, 2018 - New tool could help prioritize recovery efforts for the poorest hit by natural disasters
October 18, 2018 - Hundreds of dietary supplements shown to contain unapproved drugs
October 18, 2018 - Active Pharmaceuticals ID’d in >700 Dietary Supplements
FDA and Opioids: Too Much Regulation or Not Enough?

FDA and Opioids: Too Much Regulation or Not Enough?

image_pdfDownload PDFimage_print

SILVER SPRING, Md. — If the FDA is looking for a streamlined approach to respond to the opioid crisis, it didn’t come from a public meeting of the agency’s Opioid Policy Steering Committee.

At the meeting Tuesday, academics, physicians, patients, advocates, and industry officials shared sometimes conflicting recommendations on how the FDA can best handle the problem.

Advocates generally fell into two camps: pain patients and their supporters, concerned that opioids are being over-regulated and becoming harder to access, and people who have lost loved ones to addiction and overdoses, and would like to see stronger restrictions on such products.

Meanwhile, healthcare experts stressed addiction and overdose prevention, better provider education and awareness efforts, and the elimination of “doctor-shopping.”

In September 2017, the FDA issued a request for comment, which said the national crisis is one that requires “action by federal agencies that may in some instances be unprecedented.” The notice solicited public input to help the agency determine what it should leverage to respond to the crisis.

President Trump declared the opioid epidemic a public health emergency a month later. Approximately 64,000 people died from opioid overdoses in 2016.

The FDA notice included a handful of direct questions for stakeholders, such as:

  • How can the agency use the available public health data to influence opioid related regulatory decisions?
  • What changes can the agency make with regard to “dispensing and packaging” to encourage proper prescribing practices?
  • Should mandatory education be required for clinicians who prescribe opioids?

At the recent meeting, agency officials also discussed whether to specify dose limits, the creation of a nationwide prescription history database, and how to assess the impact of prescription drug monitoring programs (PDMP).

With regard to provider education, “there is no evidence, in the published literature, that mandatory education increases knowledge or changes behavior and practice,” pointed out Norman Kahn, MD, of the Conjoint Committee on Continuing Education. “If the goal is to count the number of people who complete the education, then of course we should make it mandatory.”

“If … the goal is to make people learn and change the behavior and practice, that doesn’t happen with mandatory education. That happens with voluntary education,” he stressed.

Kahn said he has discussed the idea of an “adaptive learning” approach with the Centers for Medicare and Medicaid Services. He said he has hopes that such an approach might count as an improvement program under the Merit-Based Incentive Payment System (MIPS).

Another concern is the language used to describe opioids, stated Diana Zuckerman, PhD, of the National Center for Health Research. She said “abuse deterrent” may mean different things to doctors, patients, and family members.

She urged the FDA to include education on the meaning of “abuse deterrent” within its Risk Evaluation and Mitigation Strategies (REMS) because “too often it’s misinterpreted to mean it’s not as addictive.”

But Zuckerman also questioned the value of REMS itself, claiming that the “vast majority” of physicians don’t even know REMS exists. Following the implementation of REMS, one prescriber-based survey found 48% of respondents said they did not change their prescribing habits, she noted. Also, while 49% said they made use of the patient counseling documents, that means roughly half did not, she added.

On the advocates’ side, Richard Lawhern, PhD, co-founder of the Alliance for the Treatment of Intractable Pain, urged the FDA to “stand down” from additional regulations on opioids.

He said that the agency is chasing the wrong crisis, as more regulation “is going to make the real crisis worse,” by driving patients into the realm of heroin and/or other illegal street drugs. He also urged the FDA to “remove and rewrite” its practice standards regarding opioids, and he dismissed the Centers for Disease Control and Prevention’s revised guidelines as “nonsense.”

Emily Walden, of Louisville, Kentucky, called on the FDA to remove the highest dose opioids from the market and “immediately delay any new approvals.” Her 22-year-old son died because of an opioid addiction, she said.

She also pressed the agency to end its use of enriched enrollment in clinical trial design. The FDA describes the method as a way to “increase the likelihood that data collected during a clinical trial will demonstrate that an effective drug is effective.”

Other topics discussed at the meeting included the need to increase e-prescribing, improve PDMP, and integrate both into electronic health records (EHR) systems.

Robert Heary, MD, of the American Association of Neurological Surgeons, suggested providers complete a short (less than 5 minutes), standardized form, with each opioid prescription, to explain why the prescription is medically justified. If a national PDMP were established, data from those forms could feed into it and be cross-checked at the pharmacy.

He noted that having a connected PDMP would prevent doctor-shopping across state lines.

Janet Woodcock, MD, director of the FDA’s Center for Drug Evaluation and Research called it a “bold proposal,” but questioned how much of a burden these additional measures would be for providers.

Patrice Harris, MD, an American Medical Association trustee and chair of the AMA’s Opioid Task Force expressed skepticism about the capacity of today’s EHRs. Recommendations on e-prescribing “overstate and overestimate the current capabilities of today’s electronic systems,” she said, adding that e-prescribing “in its current state” may not be suited to “explain medical necessity.”

While physicians may prefer e-prescribing, the pin numbers, passwords, and authentication processes can be “onerous” and may take time away from direct patient care, she added.

1969-12-31T19:00:00-0500

last updated

Tagged with:

About author

Related Articles